New location features expanded retail space, enhanced product selection and custom mural celebrating Fishtown's unique character
STAMFORD, Conn., Sept. 16, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the relocation of its Passyunk, Pennsylvania dispensary to a new, expanded location in Philadelphia's vibrant Fishtown neighborhood. Located at 1321 N. Front St., Curaleaf Fishtown will open and serve patients on Thursday, September 17, maintaining Curaleaf's footprint of 18 stores in Pennsylvania and 179 locations nationwide.
Conveniently situated near Interstate 95, the Delaware River waterfront and Rivers Casino Philadelphia, Curaleaf Fishtown offers patients an expanded storefront, greater product selection and a welcoming retail experience designed to serve both new and experienced cannabis consumers.
"Pennsylvania continues to be one of the most important medical cannabis markets in the country, and we are excited to deepen our commitment to patients in Philadelphia with the opening of our new Fishtown dispensary," said Boris Jordan, Chairman and CEO of Curaleaf. "This new location allows us to offer a broader assortment of products, an enhanced shopping experience and convenient access for patients throughout the city. We look forward to becoming part of the Fishtown community and continuing to provide the quality, education and service that patients expect from Curaleaf."
The dispensary features a custom mural created by Philadelphia-based VURT Creative artists Kristin and Evan, drawing inspiration from Fishtown's distinctive culture and maritime heritage. The artwork celebrates the neighborhood's creative spirit and serves as a vibrant focal point for patients visiting the new location.
Patients at Curaleaf Fishtown will have access to Curaleaf's extensive portfolio of trusted cannabis brands, including Grassroots, FIND, Select, and Dark Heart, as well as the recently launched Select Briq 2 all-in-one vape device. The dispensary's knowledgeable team members are available to help patients navigate product options and identify solutions tailored to their individual needs.
To celebrate the opening, Curaleaf will host a grand opening event on Wednesday, September 23, featuring local food trucks, live music, games, photo moments, special promotions and appearances from Curaleaf brand partners. Curaleaf Fishtown is open Monday through Saturday from 9:00 a.m. to 8:00 p.m. and Sunday from 9:00 a.m. to 7:00 p.m.
For more information on Curaleaf's Pennsylvania dispensaries, products, and patient resources, please visit https://curaleaf.com/dispensary/pennsylvania.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Philadelphia, Pennsylvania. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is discussed in the Company's Form 8-K dated August 5, 2026 together with the annual report on Form 10-K for the year ended December 31, 2025 and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, attached as exhibits thereto, as well as the Form 10-Q for the quarter ended June 30, 2026, each of which documents have been filed on the Company's EDGAR profile at www.sec.gov/edgar and SEDAR+ profile at www.sedarplus.ca, and as described from time to time in documents filed by the Company with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com
Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-opens-new-fishtown-dispensary-expanding-access-for-philadelphia-patients-302880346.html
SOURCE Curaleaf Holdings, Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2026/16/c8048.html